TFAP2C has been reported to be upregulated in various types of cancer, including lung carcinoma, breast cancer, and high expression of TFAP2C significantly correlated with poor prognosis via promoting the growth and proliferation [40, 43, 44]. This evidence concerns the gene TFAP2C and breast cancer.